Time to Prostate-Specific Antigen Nadir After Androgen Suppression Therapy for Postoperative or Postradiation PSA Failure and Risk of Prostate Cancer-Specific Mortality-Reference-Cited by-同舟云学术

Time to Prostate-Specific Antigen Nadir After Androgen Suppression Therapy for Postoperative or Postradiation PSA Failure and Risk of Prostate Cancer-Specific Mortality

Published:2008-01 Issue:1 Volume:71 Page:136-140
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Chung Christine S.,Chen Ming-Hui,Cullen Jennifer,McLeod David,Carroll Peter,D’Amico Anthony V.

Publisher

Elsevier BV

Subject

Urology

Reference16 articles.

1. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

2. 10-year outcome for men with localized prostate cancer treated with external radiation therapy: results of a cohort study;Zietman;J Urol,2004

3. Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy;D’Amico;J Natl Cancer Inst,2003

4. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy;Zhou;J Clin Oncol,2005

5. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy;Freedland;JAMA,2005

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correction: Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value;PLOS ONE;2022-06-08

2. Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value;PLOS ONE;2021-05-03

3. Prostate‐specific antigen nadir and testosterone level at prostate‐specific antigen failure following radiation and androgen suppression therapy for unfavorable‐risk prostate cancer and the risk of all‐cause and prostate cancer–specific mortality;Cancer;2021-04-06

4. PSA nadir and time to PSA nadir during initial androgen deprivation therapy as prognostic factors in metastatic castration‐resistance prostate cancer patients treated with docetaxel;Andrologia;2021-02-16

5. Time to Prostate-specific Antigen Nadir and the Risk of Death From Prostate Cancer Following Radiation and Androgen Deprivation Therapy;Urology;2019-04